The antiglaucoma drug landscape is preparing for a significant transformation, with forecasts indicating a market size of USD 11.57 billion by 2035. This impressive growth, reflecting a considerable increase from USD 8.20 billion in 2024, underscores the escalating need for effective glaucoma treatments. The anticipated CAGR of 3.17% highlights the increasing demand driven by a combination of...